Gatti M.; Fusaroli M.; Caraceni P.; Poluzzi E.; De Ponti F.; Raschi E., Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 87, pp. 1533 - 1540 [articolo]
Garuti F.
,
Neri A.
,
Avanzato F.
,
Gramenzi A.
,
Rampoldi D.
,
Rucci P.
,
Farinati F.
,
Giannini E.G.
,
Piscaglia F.
,
Rapaccini G.L.
,
Di Marco M.
,
Caturelli E.
,
Zoli M.
,
Sacco R.
,
Cabibbo G.
,
Marra F.
,
Mega A.
,
Morisco F.
,
Gasbarrini A.
,
Svegliati-Baroni G.
,
Foschi F.G.
,
Missale G.
,
Masotto A.
,
Nardone G.
,
Raimondo G.
,
Azzaroli F.
,
Vidili G.
,
Brunetto M.R.
,
Trevisani F.
,
Biselli M.
,
Caraceni P.
,
Garuti F.
,
Gramenzi A.
,
Neri A.
,
Santi V.
,
Granito A.
,
Muratori L.
,
Sansone V.
,
Tovoli F.
,
Dajti E.
,
Marasco G.
,
Ravaioli F.
,
Cappelli A.
,
Golfieri R.
,
Mosconi C.
,
Renzulli M.
,
Cela E.M.
,
Facciorusso A.
,
Cacciato V.
,
Casagrande E.
,
Moscatelli A.
,
Pellegatta G.
,
de Matthaeis N.
,
Allegrini G.
,
Lauria V.
,
Ghittoni G.
,
Pelecca G.
,
Chegai F.
,
Coratella F.
,
Ortenzi M.
,
Biasini E.
,
Olivani A.
,
Inno A.
,
Marchetti F.
,
Busacca A.
,
Cabibbo G.
,
Camma C.
,
Di Martino V.
,
Rizzo G.E.M.
,
Franze M.S.
,
Saitta C.
,
Sauchella A.
,
Bevilacqua V.
,
Berardinelli D.
,
Borghi A.
,
Gardini A.C.
,
Conti F.
,
Cucchetti A.
,
Dall'Aglio A.C.
,
Ercolani G.
,
Campani C.
,
Di Bonaventura C.
,
Gitto S.
,
Malerba P.C.A.
,
Capasso M.
,
Guarino M.
,
Oliveri F.
,
Romagnoli V., The changing scenario of hepatocellular carcinoma in Italy: an update, «LIVER INTERNATIONAL», 2021, 41, pp. 585 - 597 [articolo]
Caraceni P.; Abraldes J.G.; Gines P.; Newsome P.N.; Sarin S.K., The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery, «JOURNAL OF HEPATOLOGY», 2021, 75, pp. S118 - S134 [articolo]Open Access
Arroyo V.; Angeli P.; Moreau R.; Jalan R.; Claria J.; Trebicka J.; Fernandez J.; Gustot T.; Caraceni P.; Bernardi M., The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis, «JOURNAL OF HEPATOLOGY», 2021, 74, pp. 670 - 685 [articolo]Open Access
Caraceni P.; Vargas V.; Sola E.; Alessandria C.; de Wit K.; Trebicka J.; Angeli P.; Mookerjee R.P.; Durand F.; Pose E.; Krag A.; Bajaj J.S.; Beuers U.; Gines P.; Juanola A.; Napoleone L.; Carol M.; Avitabile E.; Thu A.M.; Cervera M.; Perez M.; Belen Rubio-Garcia A.; Ardiaca A.; Vives A.; Pich J.; Fabrellas N.; Zaccherini G.; Chiappa M.T.; Jimenez C.; Palacio E.; Campion D.; Lanzillotti T.; Piano S.; Nicolao G.; Uschner F.; Graf_Dirmeier S.; Francoz C.; Roux O.; Esnault V.; Helder J.; Aban M.; Kazankov K.; Korenjak M.; Kamath P.; Abraldes J.G.; Watson H., The Use of Rifaximin in Patients With Cirrhosis, «HEPATOLOGY», 2021, 74, pp. 1660 - 1673 [articolo]Open Access
Pose E.; Sola E.; Lozano J.J.; Juanola A.; Sidorova J.; Zaccherini G.; de Wit K.; Uschner F.; Tonon M.; Kazankov K.; Jimenez C.; Campion D.; Napoleone L.; Ma A.T.; Carol M.; Morales-Ruiz M.; Alessandria C.; Beuers U.; Caraceni P.; Francoz C.; Durand F.; Mookerjee R.P.; Trebicka J.; Vargas V.; Piano S.; Watson H.; Abraldes J.G.; Kamath P.S.; Davis M.M.; Gines P.; Schulz M.; Ferstl P.; Giovo I.; Roux O.; Simon-Talero M.; Perez-Guasch M.; Rubio A.B.; Cervera M.; Martinez S.; Fabrellas N.; Pich J.; Vives A.; Avitabile E.; Graupera I.; Sole C.; Bassegoda O.; Gratacos-Gines J.; Joyera M.; Palacio E.; Aban M.; Lanzillotti T.; Nicolao G.; Chiappa M.T.; Esnault V.; Andrade R.; Pavesi M.; Korenjak M.; Farres J.; Serra-Burriel M.; Angeli P., Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis, «HEPATOLOGY COMMUNICATIONS», 2021, 0, pp. 1 - 13 [articolo]Open Access
Claria J.; Curto A.; Moreau R.; Colsch B.; Lopez-Vicario C.; Lozano J.J.; Aguilar F.; Castelli F.A.; Fenaille F.; Junot C.; Zhang I.; Vinaixa M.; Yanes O.; Caraceni P.; Trebicka J.; Fernandez J.; Angeli P.; Jalan R.; Arroyo V., Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis, «JOURNAL OF HEPATOLOGY», 2021, 75, pp. 1116 - 1127 [articolo]Open Access
Bossi M.M.; Tufoni M.; Zaccherini G.; Antognoli A.; Domenicali M.; Caraceni P., A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic, «DIGESTIVE AND LIVER DISEASE», 2020, 52, pp. 956 - 957 [replica/breve intervento]
Bernardi M.; Angeli P.; Claria J.; Moreau R.; Gines P.; Jalan R.; Caraceni P.; Fernandez J.; Gerbes A.L.; O'Brien A.J.; Trebicka J.; Thevenot T.; Arroyo V., Albumin in decompensated cirrhosis: New concepts and perspectives, «GUT», 2020, 69, pp. 1127 - 1138 [articolo]
Tufoni M.; Zaccherini G.; Caraceni P.; Bernardi M., Albumin: Indications in chronic liver disease, «UNITED EUROPEAN GASTROENTEROLOGY JOURNAL», 2020, 8, pp. 528 - 535 [articolo]
Ravaioli M.; De Pace V.; Angeletti A.; Comai G.; Vasuri F.; Baldassarre M.; Maroni L.; Odaldi F.; Fallani G.; Caraceni P.; Germinario G.; Donadei C.; Malvi D.; Del Gaudio M.; Bertuzzo V.R.; Siniscalchi A.; Ranieri V.M.; D'Errico A.; Pasquinelli G.; Morelli M.C.; Pinna A.D.; Cescon M.; La Manna G., Author Correction: Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors: First Italian Clinical Trial (Scientific Reports, (2020), 10, 1, (6063), 10.1038/s41598-020-62979-9), «SCIENTIFIC REPORTS», 2020, 10, pp. 1 - 3 [replica/breve intervento]Open Access
Raschi E.; Caraceni P.; Poluzzi E.; De Ponti F., Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?, «EXPERT OPINION ON DRUG SAFETY», 2020, 19, pp. 1367 - 1369 [replica/breve intervento]
Moreau, Richard; Clària, Joan; Aguilar, Ferran; Fenaille, François; Lozano, Juanjo; Junot, Christophe; Colsch, Benoit; Caraceni, Paolo; Trebicka, Jonel; Pavesi, Marco; Alessandria, Carlo; Nevens, Frederik; Saliba, Faouzi; Welzel, Tania M.; Albillos, Agustin; Gustot, Thierry; Fernández, Javier; Moreno, Christophe; Baldasarre, Maurizio; Zaccherini, Giacomo; Piano, Salvatore; Montagnese, Sara; Vargas, Victor; Genescà, Joan; Solà, Elsa; Bernal, William; Butin, Noémie; Hautbergue, Thaïs; Cholet, Sophie; Castelli, Florence; Jansen, Christian; Steib, Christian; Campion, Daniela; Mookerjee, Raj; Rodríguez-Gandía, Miguel; Soriano, German; Durand, François; Benten, Daniel; Bañares, Rafael; Stauber, Rudolf E.; Gronbaek, Henning; Coenraad, Minneke J.; Ginès, Pere; Gerbes, Alexander; Jalan, Rajiv; Bernardi, Mauro; Arroyo, Vicente; Angeli, Paolo, Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF, «JOURNAL OF HEPATOLOGY», 2020, 72, pp. 688 - 701 [articolo]
Trieb M.; Rainer F.; Stadlbauer V.; Douschan P.; Horvath A.; Binder L.; Trakaki A.; Knuplez E.; Scharnagl H.; Stojakovic T.; Heinemann A.; Mandorfer M.; Paternostro R.; Reiberger T.; Pitarch C.; Amoros A.; Gerbes A.; Caraceni P.; Alessandria C.; Moreau R.; Claria J.; Marsche G.; Stauber R.E., HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure, «JOURNAL OF HEPATOLOGY», 2020, 73, pp. 113 - 120 [articolo]Open Access
Tufoni, Manuel; Baldassarre, Maurizio; Zaccherini, Giacomo; Antognoli, Agnese; Caraceni, Paolo, Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease, «CURRENT HEPATOLOGY REPORTS», 2020, 19, pp. 147 - 158 [articolo]Open Access
